Ratings for Bicycle Therapeutics (NASDAQ:BCYC) were provided by 4 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 2 | 1 | 1 | 0 | 0 |
| Last 30D | 2 | 1 | 1 | 0 | 0 |
| 1M Ago | 0 | 0 | 0 | 0 | 0 |
| 2M Ago | 0 | 0 | 0 | 0 | 0 |
| 3M Ago | 0 | 0 | 0 | 0 | 0 |
The 12-month price targets, analyzed by analysts, offer insights with an average target of $42.25, a high estimate of $55.00, and a low estimate of $28.00. This current average has decreased by 2.87% from the previous average price target of $43.50.
Exploring Analyst Ratings: An In-Depth Overview
In examining recent analyst actions, we gain insights...
Login or create a forever free account to read this news
Sign up/Log in